Skip to content

The effectiveness of Natural Orifice Uterine Suspension for advanced uterine prolapse: A national multicenter study

The effectiveness of Natural Orifice Uterine Suspension for advanced uterine prolapse: A national multicenter study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081807
Enrollment
Unknown
Registered
2024-03-13
Start date
2024-03-13
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic organ prolapse

Interventions

patients underwent the Natural Orifice Uterine Suspension (the Natural Orifice Uterine Suspension):None

Sponsors

Department of Urology, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. patients with advanced uterine prolapse (POP-Q stage >II) who prefer surgical treatment; 2. age =65 years old; 3. patients with an atrophic uterus.

Exclusion criteria

Exclusion criteria: 1. patients with a history of total or partial hysterectomy; 2. patients with any gynaecological malignancy or pathology (e.g., fibroids, adenomyosis, abnormal uterine bleeding, and cervical dysplasia); 3. patients with total or partial trachelectomy; 4. patients with a history of pelvic radiotherapy; 5. patients with a history of lower abdominal or pelvic operation; 6. coagulopathy; 7. any contraindication to general anesthesia surgeries.

Design outcomes

Primary

MeasureTime frame
objective cure;subjective cure;

Secondary

MeasureTime frame
pelvic organ prolapse quantitation score;Pelvic Floor Impact Questionnaire (PFIQ - 7);Pelvic Floor Distress Inventory (PFDI - 20);

Countries

China

Contacts

Public Contactdeyi luo

Department of Urology, West China Hospital, Sichuan University

luodeyi@scu.edu.cn+86 189 8060 6809

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026